David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Check Point Software Technologies
CHKP
$13.3B
| $37.8M | 0.05% |
298,692
-222,094
| -43% | -$25.8M |
|
452
American Electric Power
AEP
$66.4B
| $37.7M | 0.05% |
450,491
+48,882
| +12% | +$3.89M |
|
|
MRC
453
DELISTED
MRC Global
MRC
| $37.6M | 0.05% |
2,149,901
-674,029
| -24% | -$11M |
|
454
Wynn Resorts
WYNN
$10.2B
| $37.5M | 0.05% |
314,690
-520,036
| -62% | -$62.1M |
|
455
CALL
Petrobras
PBR
$120B
| $37.5M | 0.05% |
2,358,400
-434,000
| -16% | -$6.89M |
|
456
Fluor
FLR
$6.86B
| $37.5M | 0.05% |
1,019,659
+588,861
| +137% | +$21.5M |
|
457
US Foods
USFD
$23.7B
| $37.4M | 0.05% |
1,072,376
-55,479
| -5% | -$1.9M |
|
|
LEXEA
458
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $37.3M | 0.05% |
870,529
-182,952
| -17% | -$7.86M |
|
459
Commault Systems
CVLT
$5.43B
| $37M | 0.05% |
571,907
-8,718
| -2% | -$563K |
|
|
B
460
PUT
Barrick Mining
B
$79.3B
| $36.9M | 0.05% |
2,693,484
-728,016
| -21% | -$9.41M |
|
461
CALL
ServiceNow
NOW
$132B
| $36.9M | 0.05% |
747,500
+50,000
| +7% | +$2.2M |
|
462
GE Aerospace
GE
$355B
| $36.7M | 0.05% |
738,004
-3,699,395
| -83% | -$174M |
|
463
Capri Holdings
CPRI
$1.55B
| $36.6M | 0.05% |
800,849
-2,737,133
| -77% | -$120M |
|
464
Campbell Soup
CPB
$7.2B
| $36.5M | 0.05% |
958,258
+188,228
| +24% | +$6.64M |
|
465
Coca-Cola Europacific Partners
CCEP
$48.6B
| $36.4M | 0.05% |
703,161
+303,556
| +76% | +$14.4M |
|
466
PUT
American Airlines Group
AAL
$9.02B
| $36.2M | 0.05% |
1,139,300
-60,700
| -5% | -$2.04M |
|
467
Devon Energy
DVN
$53.1B
| $36M | 0.05% |
1,140,855
-594,688
| -34% | -$16.6M |
|
468
Heron Therapeutics
HRTX
$61.3M
| $36M | 0.05% |
1,471,596
+417,588
| +40% | +$10.9M |
|
|
AAN.A
469
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $36M | 0.05% |
683,707
+292,529
| +75% | +$15.4M |
|
470
Pacira BioSciences
PCRX
$991M
| $35.9M | 0.05% |
942,444
+570,237
| +153% | +$22.3M |
|
471
Sally Beauty Holdings
SBH
$1.56B
| $35.9M | 0.05% |
1,947,697
-735,555
| -27% | -$13.1M |
|
472
Elanco Animal Health
ELAN
$12.2B
| $35.7M | 0.05% |
1,112,278
-369,971
| -25% | -$11.4M |
|
473
H&R Block
HRB
$6.62B
| $35.7M | 0.05% |
1,489,302
-527,714
| -26% | -$13M |
|
|
WW
474
DELISTED
WW International
WW
| $35.6M | 0.05% |
+1,766,790
| New | +$48.8M |
|
475
CALL
SLB Ltd
SLB
$80.1B
| $35.4M | 0.05% |
812,200
+403,800
| +99% | +$17.5M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.